VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
-2.68%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$732M
AUM Growth
+$732M
(-6%)
Cap. Flow
+$60.5M
Cap. Flow
% of AUM
8.27%
Top 10 Holdings %
Top 10 Hldgs %
70.9%
Holding
29
New
3
Increased
6
Reduced
5
Closed
3
Top Buys
| 1 |
Viridian Therapeutics
VRDN
|
$36.2M |
| 2 |
LIAN
LianBio American Depositary Shares
LIAN
|
$33.1M |
| 3 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$29.7M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$20.9M |
| 5 |
Relmada Therapeutics
RLMD
|
$19.9M |
Top Sells
| 1 |
Altimmune
ALT
|
$43M |
| 2 |
Cullinan Oncology
CGEM
|
$15.9M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$12.4M |
| 4 |
Pharvaris
PHVS
|
$9.8M |
| 5 |
Celldex Therapeutics
CLDX
|
$9.01M |
Sector Composition
| 1 | Healthcare | 95.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Instil Bio
TIL
$182M
| $117M | 16.06% | 6,865,076 | – | – |
|
2
Aclaris Therapeutics
ACRS
$209M
| $66.4M | 9.07% | 4,563,962 | – | – |
|
3
Travere Therapeutics
TVTX
$1.56B
| $61.9M | 8.47% | 1,994,997 +262,587 | +15% | +$8.15M |
|
|
4
Relmada Therapeutics
RLMD
$37.2M
| $51.1M | 6.99% | 2,270,072 +882,352 | +64% | +$19.9M |
|
5
GH Research
GHRS
$837M
| $47.2M | 6.45% | 2,021,985 +379,689 | +23% | +$8.86M |
|
|
WHWK
6
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $36.9M | 5.05% | 1,529,402 | – | – |
|
|
7
Viridian Therapeutics
VRDN
$1.5B
| $36.6M | 5.01% | 1,852,919 +1,833,424 | +9,405% | +$36.2M |
|
|
MRNS
8
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $34.2M | 4.68% | 2,880,096 +238,287 | +9% | +$2.83M |
|
|
9
Celldex Therapeutics
CLDX
$1.47B
| $33.4M | 4.57% | 865,116 -233,058 | -21% | -$9.01M |
|
|
TCDA
10
DELISTED
Tricida, Inc. Common Stock
TCDA
| $33.4M | 4.57% | 3,494,851 +3,104,144 | +794% | +$29.7M |
|
|
LIAN
11
DELISTED
LianBio American Depositary Shares
LIAN
| $33.1M | 4.53% | +5,378,341 | New | +$33.1M |
|
12
VistaGen Therapeutics
VTGN
$102M
| $31.3M | 4.28% | 16,047,286 | – | – |
|
|
KDNY
13
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $20.9M | 2.86% | +1,283,821 | New | +$20.9M |
|
|
LENZ
14
LENZ Therapeutics
LENZ
$1.1B
| $20M | 2.74% | 1,612,617 | – | – |
|
15
Nuvalent
NUVL
$5.52B
| $15.3M | 2.09% | 803,951 | – | – |
|
|
KNTE
16
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $13.7M | 1.87% | 773,014 -700,000 | -48% | -$12.4M |
|
17
Athira Pharma
ATHA
$15.3M
| $13M | 1.78% | 1,000,000 -196,196 | -16% | -$2.56M |
|
|
CNTA
18
Centessa Pharmaceuticals
CNTA
$2.25B
| $12.7M | 1.74% | 1,127,272 | – | – |
|
|
ATYR
19
aTyr Pharma
ATYR
$527M
| $11.7M | 1.6% | 1,565,000 | – | – |
|
20
Cogent Biosciences
COGT
$1.69B
| $9.34M | 1.28% | 1,088,817 | – | – |
|
|
AFMD
21
DELISTED
Affimed
AFMD
| $7.89M | 1.08% | +1,428,571 | New | +$7.89M |
|
22
Olema Pharmaceuticals
OLMA
$375M
| $7.64M | 1.04% | 816,651 -719,542 | -47% | -$6.74M |
|
23
CVRx
CVRX
$205M
| $6.52M | 0.89% | 533,370 | – | – |
|
|
AKYA
24
DELISTED
Akoya BioSciences
AKYA
| $6.12M | 0.84% | 400,000 | – | – |
|
25
Astria Therapeutics
ATXS
$349M
| $2.91M | 0.4% | 538,999 | – | – |
|